GDNF Gene Therapy for Parkinson’s Disease
Condition(s):Parkinson’s DiseaseLast Updated:January 19, 2023Active, not recruiting
Hide Studies Not Open or Pending
Condition(s):Parkinson’s DiseaseLast Updated:January 19, 2023Active, not recruiting
Condition(s):Gait Disorders, Neurologic; Parkinson DiseaseLast Updated:March 6, 2024Not yet recruiting
Condition(s):Parkinson’s DiseaseLast Updated:December 6, 2021Completed
Condition(s):Parkinson DiseaseLast Updated:May 18, 2023Not yet recruiting
Condition(s):Parkinson Disease; Dyskinesia, Drug-Induced; LevodopaLast Updated:December 23, 2020Completed
Condition(s):Parkinson’s DiseaseLast Updated:December 21, 2023Recruiting
Condition(s):Parkinson DiseaseLast Updated:April 12, 2023Terminated
Condition(s):Parkinson’s DiseaseLast Updated:January 31, 2017Completed
Condition(s):Parkinson’s Disease With Motor FluctuationsLast Updated:April 12, 2019Terminated
Condition(s):Alzheimer Disease; Parkinson DiseaseLast Updated:August 8, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.